Axsome Therapeutics (AXSM) Goodwill & Intangibles (2022 - 2026)

Axsome Therapeutics has reported Goodwill & Intangibles for 5 years, with the latest figure at $50.9 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 11.12% year-over-year to $50.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.9 million (down 11.12% YoY) and the FY2025 annual result came in at $75.8 million, up 28.61% from the prior year.
• Goodwill & Intangibles slipped to $50.9 million in Q1 2026 per AXSM's latest filing, from $75.8 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $75.8 million in Q4 2023 and troughed at $50.9 million in Q1 2026.
• A 5-year average of $65.7 million and a median of $65.3 million in 2023 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles surged 33.86% in 2024, then fell 28.54% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $74.1 million in 2022, then climbed by 2.28% to $75.8 million in 2023, then slipped by 22.25% to $58.9 million in 2024, then increased by 28.61% to $75.8 million in 2025, then slumped by 32.79% to $50.9 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $50.9 million, $75.8 million, and $54.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.